Einav Zeevi

664 total citations
33 papers, 465 citations indexed

About

Einav Zeevi is a scholar working on Biomedical Engineering, Biotechnology and Molecular Biology. According to data from OpenAlex, Einav Zeevi has authored 33 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Biomedical Engineering, 10 papers in Biotechnology and 9 papers in Molecular Biology. Recurrent topics in Einav Zeevi's work include 3D Printing in Biomedical Research (13 papers), Cancer Research and Treatments (6 papers) and Microfluidic and Bio-sensing Technologies (5 papers). Einav Zeevi is often cited by papers focused on 3D Printing in Biomedical Research (13 papers), Cancer Research and Treatments (6 papers) and Microfluidic and Bio-sensing Technologies (5 papers). Einav Zeevi collaborates with scholars based in United States, Switzerland and Israel. Einav Zeevi's co-authors include Moshe Giladi, Tali Voloshin, Yoram Palti, Rosa S. Schneiderman, Uri Weinberg, Anna Shteingauz, Eilon D. Kirson, Noa Kaynan, Mijal Munster and Yaara Porat and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Einav Zeevi

32 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Einav Zeevi United States	8	193	178	142	92	91	33	465
Roni Blat Switzerland	7	295 1.5×	217 1.2×	155 1.1×	130 1.4×	110 1.2×	21	580
Adrian Kinzel United States	9	192 1.0×	136 0.8×	95 0.7×	79 0.9×	71 0.8×	35	401
Shay Cahal United States	7	266 1.4×	276 1.6×	166 1.2×	119 1.3×	116 1.3×	22	640
Noa Urman United States	7	220 1.1×	210 1.2×	111 0.8×	85 0.9×	58 0.6×	36	488
Narasimha Kumar Karanam United States	8	135 0.7×	108 0.6×	158 1.1×	66 0.7×	77 0.8×	19	395
Aafia Chaudhry United States	9	186 1.0×	141 0.8×	91 0.6×	83 0.9×	238 2.6×	49	542
Guangrong Lu United States	10	195 1.0×	95 0.5×	215 1.5×	63 0.7×	91 1.0×	21	487
Inderjit Daphu Norway	6	166 0.9×	93 0.5×	143 1.0×	82 0.9×	116 1.3×	6	398
Mijal Munster United States	12	414 2.1×	338 1.9×	238 1.7×	190 2.1×	158 1.7×	51	878
Frank Rommel Germany	9	228 1.2×	44 0.2×	98 0.7×	46 0.5×	77 0.8×	15	448

Countries citing papers authored by Einav Zeevi

Since Specialization

Citations

This map shows the geographic impact of Einav Zeevi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Einav Zeevi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Einav Zeevi more than expected).

Fields of papers citing papers by Einav Zeevi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Einav Zeevi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Einav Zeevi. The network helps show where Einav Zeevi may publish in the future.

Co-authorship network of co-authors of Einav Zeevi

This figure shows the co-authorship network connecting the top 25 collaborators of Einav Zeevi. A scholar is included among the top collaborators of Einav Zeevi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Einav Zeevi. Einav Zeevi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Shteingauz, Anna, Catherine Tempel-Brami, Einav Zeevi, et al.. (2022). Tumor treating fields (TTFields) in combination with sorafenib inhibit hepatocellular carcinoma in vitro and in vivo.. Journal of Clinical Oncology. 40(4_suppl). 464–464. 1 indexed citations

2.

Shteingauz, Anna, Catherine Tempel-Brami, Einav Zeevi, et al.. (2022). Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo. Cancers. 14(12). 2959–2959. 21 indexed citations

3.

Voloshin, Tali, Noa Kaynan, Yaara Porat, et al.. (2020). Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy. Cancer Immunology Immunotherapy. 69(7). 1191–1204. 114 indexed citations

4.

Tempel-Brami, Catherine, Einav Zeevi, Rosa S. Schneiderman, et al.. (2020). P-261 Safety and effectiveness of tumor treating fields combined with sorafenib in preclinical models of hepatocellular carcinoma. Annals of Oncology. 31. S175–S175. 1 indexed citations

5.

Zeevi, Einav, et al.. (2020). Regulation of axonal morphogenesis by the mitochondrial protein Efhd1. Life Science Alliance. 3(7). e202000753–e202000753. 18 indexed citations

6.

Voloshin, Tali, Rosa S. Schneiderman, Reuben R. Shamir, et al.. (2020). Tumor Treating Fields (TTFields) Hinder Cancer Cell Motility through Regulation of Microtubule and Actin Dynamics. Cancers. 12(10). 3016–3016. 63 indexed citations

7.

Shahaf, Gitit, Moshe Giladi, Rosa S. Schneiderman, et al.. (2020). Abstract 2411: Cancer cell lines meta-analysis according to both short-term and long-term responses to Tumor Treating Fields (TTFields). Cancer Research. 80(16_Supplement). 2411–2411. 1 indexed citations

8.

Voloshin, Tali, Noa Kaynan, Yaara Porat, et al.. (2020). Immunomodulatory effects of tumor treating fields (TTFields) on colon cancer models.. Journal of Clinical Oncology. 38(4_suppl). 136–136. 1 indexed citations

9.

Zeevi, Einav, Tali Voloshin, Moshe Giladi, et al.. (2019). The combined treatment of 150 kHz Tumor Treating Fields (TTFields) and sorafenib shows In vitro and in vivo efficacy in hepatocellular carcinoma. Annals of Oncology. 30. iv68–iv68. 1 indexed citations

10.

Munster, Mijal, Rosa S. Schneiderman, Yaara Porat, et al.. (2019). Abstract 307: The combined treatment of 150 kHz Tumor Treating Fields (TTFields) and Cisplatin or Pemetrexed inhibit mesothelioma cells in vitro. Cancer Research. 79(13_Supplement). 307–307. 1 indexed citations

11.

Giladi, Moshe, Einav Zeevi, Cornelia Wenger, et al.. (2019). CBMT-13. 3DEP SYSTEM TO TEST THE ELECTRICAL PROPERTIES OF DIFFERENT CELL LINES AS PREDICTIVE MARKERS OF OPTIMAL TUMOR TREATING FIELDS (TTFIELDS) FREQUENCY AND SENSITIVITY. Neuro-Oncology. 21(Supplement_6). vi35–vi35. 1 indexed citations

12.

Zeevi, Einav, Rosa S. Schneiderman, Mijal Munster, et al.. (2019). The Combined Treatment of 150 kHz Tumor Treating Fields (TTFields) and FOLFOX Inhibit Gastric Cancer in Vitro. International Journal of Radiation Oncology*Biology*Physics. 105(1). E681–E681. 1 indexed citations

13.

Weinberg, Uri, Noa Kaynan, Yaara Porat, et al.. (2019). Immunomodulatory effects of Tumor Treating Fields (TTFields) on lung cancer models. Annals of Oncology. 30. ii2–ii3. 5 indexed citations

14.

Zeevi, Einav, et al.. (2019). Abstract 5156: In vitro application of tumor-treating fields to suppress tunneling nanotubes in mesothelioma. Cancer Research. 79(13_Supplement). 5156–5156. 2 indexed citations

15.

Munster, Mijal, Rosa S. Schneiderman, Yaara Porat, et al.. (2019). Efficacy of Tumor Treating Fields (TTFields) in Combination with Cisplatin or Pemetrexed for the Treatment of Mesothelioma in Vitro and in Vivo. International Journal of Radiation Oncology*Biology*Physics. 105(1). E679–E679. 1 indexed citations

16.

Shteingauz, Anna, Yaara Porat, Tali Voloshin, et al.. (2018). AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields). Cell Death and Disease. 9(11). 1074–1074. 82 indexed citations

17.

Schneiderman, Rosa S., Moshe Giladi, Einav Zeevi, et al.. (2018). ANGI-11. TUMOR TREATING FIELDS (TTFIELDS) INHIBIT CANCER CELL MIGRATION AND INVASION BY INDUCING REORGANIZATION OF THE ACTIN CYTOSKELETON AND FORMATION OF CELL ADHESIONS. Neuro-Oncology. 20(suppl_6). vi30–vi30. 4 indexed citations

18.

Porat, Yaara, Moshe Giladi, Rosa S. Schneiderman, et al.. (2017). Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields). Journal of Visualized Experiments. 23 indexed citations

19.

Porat, Yaara, Moshe Giladi, Rosa S. Schneiderman, et al.. (2017). Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields). Journal of Visualized Experiments. 46 indexed citations

20.

Groves, Morris D., Rosa S. Schneiderman, Einav Zeevi, et al.. (2016). NIMG-39. CYTOSTATIC AGENTS COMBINED WITH TUMOR TREATING FIELDS (TTFIELDS) IN GLIOMA CELL LINES. Neuro-Oncology. 18(suppl_6). vi133–vi133. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact